EMD527040 (Standard)
EMD527040 (Standard) is the analytical standard of EMD527040 (HY-101473). This product is intended for research and analytical applications. EMD527040 is a potent and highly selective αvβ6 antagonist with antifibrotic activities. EMD527040 can be used for carcinoma and liver fibrosis research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 851333-14-7
- 分子式: C29H32Cl2N4O5
- 分子量:587.49
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-13535
ATN-161α5β1/αvβ3 Integrin Binder -
HY-17369B
TirofibanGp IIb/IIIa Receptor Antagonist -
HY-12290
Arg-Gly-Asp-SerIntegrin Inhibitor -
HY-P0023
Cyclo(-RGDfK)αvβ3 Integrin Inhibitor -
HY-100506
GLPG0187Integrin Receptor Antagonist -
HY-14571
E7820Angiogenesis Inhibitor -
HY-137561
Bexotegrastαvβ6/αvβ1 Integrin Inhibitor -
HY-100226
A-205804E-selectin/ICAM-1 Inhibitor -
HY-18644
CWHM-12αV Integrins Inhibitor -
HY-13535A
ATN-161 trifluoroacetate saltIntegrin Antagonist -
HY-15102
MK-0429αvβ3 Integrin Inhibitor -
HY-19307
SB-273005αvβ3/αvβ5 Receptor Antagonist
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 851333-14-7
-
分子量 587.49
-
分子式 C29H32Cl2N4O5
-
SMILES
O=C(O)CC(NC([C@@H](NC(CCCCNC1=NC=CC=C1)=O)COCC2=CC=CC=C2)=O)C3=CC(Cl)=CC(Cl)=C3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Eleonora Patsenker, et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology. 2008 Aug;135(2):660-70. [Content Brief]
[2]. Yury Popov, et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
EMD527040 (Standard) 関連分類
HY-101473R 関連分類
Powered by Bioz